Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
The New Zealand Medical Journal
|
February 22, 2019
The cost of teriflunomide in the treatment of relapsing-remitting multiple sclerosis
J Alasdair Millar
Clinical Epidemiology
|
November 16, 2012
Measures of risk and their relationship to the relative size of a high-risk group: application to medical thromboprophylaxis
J Alasdair Millar
The Medical Journal of Australia
|
April 21, 2009
Genesis of medical thromboprophylaxis guidelines in Australia: a need for transparency and standardisation in guideline development
J Alasdair Millar
The Australasian Medical Journal
|
October 15, 2015
Effect of medical thromboprophylaxis on mortality from pulmonary embolus and major bleedingy
J Alasdair Millar
The New Zealand Medical Journal
|
March 3, 2012
The Cockroft and Gault formula for estimation of creatinine clearance: a friendly deconstruction
J Alasdair Millar
The Medical Journal of Australia
|
November 4, 2008
Rational thromboprophylaxis in medical inpatients: not quite there yet
J Alasdair Millar
The Australasian Medical Journal
|
March 11, 2014
Current state of medical thromboprophylaxis in Australia
Sophie E Noel, J Alasdair Millar
Pharmacoeconomics
|
May 10, 2007
Cost effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a lifetime model
J Alasdair Millar, Michael J Millward
The Australasian Medical Journal
|
October 4, 2014
Potential cost to Western Australia of proposed patient co-payments according to healthcare organisational structure: A preliminary analysis
J Alasdair Millar, Robyn C Millar
The Medical Journal of Australia
|
January 22, 2008
The national inpatient medication chart: critical audit of design and performance at a tertiary hospital
J Alasdair Millar, Robyn C Silla, Glenda E Lee, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
The New Zealand Medical Journal
|
February 22, 2019
The cost of teriflunomide in the treatment of relapsing-remitting multiple sclerosis
J Alasdair Millar
Clinical Epidemiology
|
November 16, 2012
Measures of risk and their relationship to the relative size of a high-risk group: application to medical thromboprophylaxis
J Alasdair Millar
The Medical Journal of Australia
|
April 21, 2009
Genesis of medical thromboprophylaxis guidelines in Australia: a need for transparency and standardisation in guideline development
J Alasdair Millar
The Australasian Medical Journal
|
October 15, 2015
Effect of medical thromboprophylaxis on mortality from pulmonary embolus and major bleedingy
J Alasdair Millar
The New Zealand Medical Journal
|
March 3, 2012
The Cockroft and Gault formula for estimation of creatinine clearance: a friendly deconstruction
J Alasdair Millar
The Medical Journal of Australia
|
November 4, 2008
Rational thromboprophylaxis in medical inpatients: not quite there yet
J Alasdair Millar
The Australasian Medical Journal
|
March 11, 2014
Current state of medical thromboprophylaxis in Australia
Sophie E Noel, J Alasdair Millar
Pharmacoeconomics
|
May 10, 2007
Cost effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a lifetime model
J Alasdair Millar, Michael J Millward
The Australasian Medical Journal
|
October 4, 2014
Potential cost to Western Australia of proposed patient co-payments according to healthcare organisational structure: A preliminary analysis
J Alasdair Millar, Robyn C Millar
The Medical Journal of Australia
|
January 22, 2008
The national inpatient medication chart: critical audit of design and performance at a tertiary hospital
J Alasdair Millar, Robyn C Silla, Glenda E Lee, et al.
Page
of 2